Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children

Children, although at lower risk of poor outcomes from COVID-19 relative to adults, still stand to benefit from therapeutic interventions. Understanding of COVID-19 clinical presentation and prognosis in children is essential to optimize therapeutic trials design. This perspective illustrates how to...

Descripción completa

Detalles Bibliográficos
Autores principales: Morin, Sébastien, Lallemant, Marc, Garcia-Prats, Anthony, Lewis, Linda, Watkins, Melynda, Giaquinto, Carlo, Valentin, Marie, Penazzato, Martina, Reeder, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658058/
https://www.ncbi.nlm.nih.gov/pubmed/34784302
http://dx.doi.org/10.1097/INF.0000000000003331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658058/
https://www.ncbi.nlm.nih.gov/pubmed/34784302
http://dx.doi.org/10.1097/INF.0000000000003331

Ejemplares similares